{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "29390373", "DateCompleted": {"Year": "2018", "Month": "02", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "05"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["e9265", "10.1097/MD.0000000000009265"], "Journal": {"ISSN": "1536-5964", "JournalIssue": {"Volume": "96", "Issue": "50", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Medicine", "ISOAbbreviation": "Medicine (Baltimore)"}, "ArticleTitle": "Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney disease: A case report.", "Pagination": {"StartPage": "e9265", "MedlinePgn": "e9265"}, "Abstract": {"AbstractText": ["Ozone autohemotherapy as an alternative treatment method has been applied to the treatment of several diseases. Here, we report a patient used ozone autohemotherapy to treat her hypertension and diabetes. Nevertheless, the patient occurred sudden dizziness and black haze due to hyperkalemia.", "A 54-year-old woman who was admitted to our emergency department complaining of sudden dizziness and black haze for 5\u200ahours.", "The blood potassium test showed hyperkalemia. Upon further inquiry of her medical history, the patient received ozone autohemotherapy to treat hypertension and diabetes for 9 days prior to admission.", "The ozone therapy had been asked to stop. Insulin, sodium bicarbonate, and sodium polystyrene sulfonate were administered to the patient.", "After treatment, blood potassium remained in the normal range. After 3 days of treatment, the 24-hour dynamic electrocardiogram revealed sinus rhythm with an average heart rate of 82\u200abeats/min, occasional ventricular premature beats, occasional ventricular premature beats, and no ST segment depression.", "Although ozone therapy is widely used in the treatment of several diseases, adverse reactions should be given attention in clinical practice, especially in patients with chronic kidney disease."], "CopyrightInformation": "Copyright \u00a9 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The General Hospital of FAW, The Fourth Hospital of Jilin University, Changchun, Jilin Province Department of Cardiovascular, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province Department of Cardiology, the Chenzhou City First People's Hospital Affiliated to University of South China, Chenzhou, Hunan Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing, China."}], "LastName": "Tang", "ForeName": "Wen-Juan", "Initials": "WJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jiang", "ForeName": "Long", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wang", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kuang", "ForeName": "Ze-Min", "Initials": "ZM"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Medicine (Baltimore)", "NlmUniqueID": "2985248R", "ISSNLinking": "0025-7974"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Electrocardiography"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["etiology", "therapy"], "DescriptorName": "Hyperkalemia"}, {"QualifierName": ["complications", "therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["complications"], "DescriptorName": "Renal Insufficiency, Chronic"}, {"QualifierName": ["etiology", "therapy"], "DescriptorName": "Sick Sinus Syndrome"}], "CoiStatement": "The authors have no conflicts of interest to disclose."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhang J, Guan M, Xie C, et al. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozonetherapy in diabetic patients with foot ulcers. Oxid Med Cell Longev 2014;2014:273475.", "ArticleIdList": ["PMC4096389", "25089169"]}, {"Citation": "Buyuklu M, Kandemir FM, Set T, et al. Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc Toxicol 2017;17:426\u201333.", "ArticleIdList": ["28097518"]}, {"Citation": "\u00dcreyen \u00c7M, Ba\u015f CY, Arslan \u015e. Myocardial infarction after ozone therapy: is ozone therapy Dr. Jekyll or Mr. Hyde? Cardiology 2015;132:101\u20134.", "ArticleIdList": ["26139204"]}, {"Citation": "Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234:279\u201393.", "ArticleIdList": ["7808295"]}, {"Citation": "Zanardi I, Borrelli E, Valacchi G, et al. Ozone: a multifaceted molecule with unexpected therapeutic activity. Curr Med Chem 2016;23:304\u201314.", "ArticleIdList": ["26687830"]}, {"Citation": "Yu G, Bai Z, Chen Z, et al. The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease. Int Immunopharmacol 2017;43:203\u20139.", "ArticleIdList": ["28038382"]}, {"Citation": "Nogales CG, Ferreira MB, Montemor AF, et al. Ozone therapy as an adjuvant for endondontic protocols: microbiological - ex vivo study and citotoxicity analyses. J Appl Oral Sci 2016;24:607\u201313.", "ArticleIdList": ["PMC5161259", "28076466"]}, {"Citation": "Lee S, Lee MY, Nam JS, et al. Hemorheological approach for early detection of chronic kidney disease and diabetic nephropathy in Type 2 diabetes. Diabetes Technol Ther 2015;17:808\u201315.", "ArticleIdList": ["26214546"]}, {"Citation": "Aydogan S, Artis AS. Artis AS. How ozone treatment affects erythrocytes. Hemodynamics - New Diagnostic and Therapeuric Approaches. Rijeka: InTech; 2012. 69\u201384."}, {"Citation": "Gill K, Fink JC, Gilbertson DT, et al. Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease. Pharmacoepidemiol Drug Saf 2015;24:654\u201362.", "ArticleIdList": ["25903095"]}], "ReferenceList": []}], "History": [{"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29390373", "PMC5815785", "10.1097/MD.0000000000009265", "00005792-201712150-00123"]}}], "PubmedBookArticle": []}